$ATRA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Atara Biotherapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Atara Biotherapeutics, Inc.. Get notifications about new insider transactions in Atara Biotherapeutics, Inc. for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 8 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 18 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 30.38 | 600 | 18,228 | 359,478 | 360.1 K to 359.5 K (-0.17 %) |
Jan 12 2018 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Option Exercise | M | 11.00 | 30,000 | 330,000 | 10,000 | |
Jan 12 2018 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Sell | S | 25.00 | 30,000 | 750,000 | 89,654 | 119.7 K to 89.7 K (-25.07 %) |
Jan 12 2018 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Sell | S | 22.32 | 3,500 | 78,120 | 119,654 | 123.2 K to 119.7 K (-2.84 %) |
Jan 12 2018 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Buy | M | 11.00 | 30,000 | 330,000 | 123,154 | 93.2 K to 123.2 K (+32.20 %) |
Jan 12 2018 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Sell | S | 20.77 | 3,500 | 72,695 | 93,154 | 96.7 K to 93.2 K (-3.62 %) |
Jan 12 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 30.05 | 100 | 3,005 | 360,078 | 360.2 K to 360.1 K (-0.03 %) |
Jan 12 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 22.01 | 17,500 | 385,175 | 360,178 | 377.7 K to 360.2 K (-4.63 %) |
Jan 12 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 21.49 | 2,500 | 53,725 | 377,678 | 380.2 K to 377.7 K (-0.66 %) |
Jan 12 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 20.38 | 4,100 | 83,558 | 380,178 | 384.3 K to 380.2 K (-1.07 %) |
Jan 12 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 19.64 | 4,500 | 88,380 | 384,278 | 388.8 K to 384.3 K (-1.16 %) |
Jan 02 2018 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Sell | S | 20.00 | 32,000 | 640,000 | 96,654 | 128.7 K to 96.7 K (-24.87 %) |
Jan 02 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 20.28 | 2,700 | 54,756 | 388,778 | 391.5 K to 388.8 K (-0.69 %) |
Jan 02 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 19.04 | 2,900 | 55,216 | 391,478 | 394.4 K to 391.5 K (-0.74 %) |
Jan 02 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 18.24 | 14,400 | 262,656 | 394,378 | 408.8 K to 394.4 K (-3.52 %) |
Jan 02 2018 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 15.15 | 2,200 | 33,330 | 408,778 | 411 K to 408.8 K (-0.54 %) |
Dec 14 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 14.73 | 2,200 | 32,406 | 410,978 | 413.2 K to 411 K (-0.53 %) |
Dec 14 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 14.56 | 2,200 | 32,032 | 413,178 | 415.4 K to 413.2 K (-0.53 %) |
Dec 01 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 14.40 | 2,200 | 31,680 | 415,378 | 417.6 K to 415.4 K (-0.53 %) |
Dec 01 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 14.09 | 2,200 | 30,998 | 417,578 | 419.8 K to 417.6 K (-0.52 %) |
Nov 17 2017 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Option Exercise | M | 0.00 | 4,146 | 0 | 2,764 | |
Nov 17 2017 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Sell | S | 15.00 | 7,000 | 105,000 | 256,236 | 263.2 K to 256.2 K (-2.66 %) |
Nov 17 2017 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Buy | M | 0.00 | 4,146 | 0 | 263,236 | 259.1 K to 263.2 K (+1.60 %) |
Nov 17 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Option Exercise | M | 0.00 | 829 | 0 | 553 | |
Nov 17 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 13.36 | 1,604 | 21,429 | 342,530 | 344.1 K to 342.5 K (-0.47 %) |
Nov 17 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Buy | M | 0.00 | 829 | 0 | 344,134 | 343.3 K to 344.1 K (+0.24 %) |
Nov 17 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Option Exercise | M | 0.00 | 5,908 | 0 | 3,938 | |
Nov 17 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Buy | M | 0.00 | 5,908 | 0 | 743,675 | 737.8 K to 743.7 K (+0.80 %) |
Nov 17 2017 | ATRA | Atara Biotherapeut ... | Clark Mitchall G. | EVP & Chief R & QA ... | Option Exercise | M | 0.00 | 7,212 | 0 | 12,019 | |
Nov 17 2017 | ATRA | Atara Biotherapeut ... | Clark Mitchall G. | EVP & Chief R & QA ... | Sell | S | 14.20 | 3,290 | 46,718 | 163,052 | 166.3 K to 163.1 K (-1.98 %) |
Nov 17 2017 | ATRA | Atara Biotherapeut ... | Clark Mitchall G. | EVP & Chief R & QA ... | Buy | M | 0.00 | 7,212 | 0 | 166,342 | 159.1 K to 166.3 K (+4.53 %) |
Nov 17 2017 | ATRA | Atara Biotherapeut ... | Fust Matthew K | Director | Option Exercise | M | 0.00 | 1,602 | 0 | 2,137 | |
Nov 17 2017 | ATRA | Atara Biotherapeut ... | Fust Matthew K | Director | Buy | M | 0.00 | 1,602 | 0 | 30,503 | 28.9 K to 30.5 K (+5.54 %) |
Nov 17 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Option Exercise | M | 0.00 | 7,697 | 0 | 5,132 | |
Nov 17 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Buy | M | 0.00 | 7,697 | 0 | 128,654 | 121 K to 128.7 K (+6.36 %) |
Nov 17 2017 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Option Exercise | M | 0.00 | 817 | 0 | 1,362 | |
Nov 17 2017 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Option Exercise | M | 0.00 | 1,549 | 0 | 1,548 | |
Nov 17 2017 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Sell | S | 14.20 | 1,184 | 16,813 | 109,738 | 110.9 K to 109.7 K (-1.07 %) |
Nov 17 2017 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Buy | M | 0.00 | 817 | 0 | 110,922 | 110.1 K to 110.9 K (+0.74 %) |
Nov 17 2017 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Buy | M | 0.00 | 1,549 | 0 | 110,105 | 108.6 K to 110.1 K (+1.43 %) |
Nov 14 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 13.41 | 2,200 | 29,502 | 419,778 | 422 K to 419.8 K (-0.52 %) |
Nov 14 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 13.53 | 2,200 | 29,766 | 421,978 | 424.2 K to 422 K (-0.52 %) |
Oct 30 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 13.60 | 2,200 | 29,920 | 424,178 | 426.4 K to 424.2 K (-0.52 %) |
Oct 30 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 13.57 | 2,200 | 29,854 | 426,378 | 428.6 K to 426.4 K (-0.51 %) |
Oct 17 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 14.35 | 6,000 | 86,100 | 343,305 | 349.3 K to 343.3 K (-1.72 %) |
Oct 12 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 14.78 | 2,200 | 32,516 | 428,578 | 430.8 K to 428.6 K (-0.51 %) |
Oct 12 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 15.25 | 2,200 | 33,550 | 430,778 | 433 K to 430.8 K (-0.51 %) |
Sep 21 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 15.56 | 2,200 | 34,232 | 432,978 | 435.2 K to 433 K (-0.51 %) |
Sep 21 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 15.51 | 2,200 | 34,122 | 435,178 | 437.4 K to 435.2 K (-0.50 %) |
Sep 18 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 15.30 | 6,000 | 91,800 | 349,305 | 355.3 K to 349.3 K (-1.69 %) |
Sep 08 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 14.98 | 2,200 | 32,956 | 437,378 | 439.6 K to 437.4 K (-0.50 %) |
Sep 08 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 15.05 | 2,200 | 33,110 | 439,578 | 441.8 K to 439.6 K (-0.50 %) |
Aug 24 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 13.51 | 2,200 | 29,722 | 441,778 | 444 K to 441.8 K (-0.50 %) |
Aug 24 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 13.56 | 2,200 | 29,832 | 443,978 | 446.2 K to 444 K (-0.49 %) |
Aug 17 2017 | ATRA | Atara Biotherapeut ... | Fust Matthew K | Director | Option Exercise | M | 0.00 | 1,603 | 0 | 3,739 | |
Aug 17 2017 | ATRA | Atara Biotherapeut ... | Fust Matthew K | Director | Buy | M | 0.00 | 1,603 | 0 | 28,901 | 27.3 K to 28.9 K (+5.87 %) |
Aug 17 2017 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Option Exercise | M | 0.00 | 818 | 0 | 2,179 | |
Aug 17 2017 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Option Exercise | M | 0.00 | 1,548 | 0 | 3,097 | |
Aug 17 2017 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Sell | S | 14.30 | 1,184 | 16,931 | 108,556 | 109.7 K to 108.6 K (-1.08 %) |
Aug 17 2017 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Buy | M | 0.00 | 818 | 0 | 109,740 | 108.9 K to 109.7 K (+0.75 %) |
Aug 17 2017 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Buy | M | 0.00 | 1,548 | 0 | 108,922 | 107.4 K to 108.9 K (+1.44 %) |
Aug 17 2017 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Option Exercise | M | 0.00 | 4,145 | 0 | 6,910 | |
Aug 17 2017 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Sell | S | 14.53 | 2,464 | 35,802 | 259,090 | 261.6 K to 259.1 K (-0.94 %) |
Aug 17 2017 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Buy | M | 0.00 | 4,145 | 0 | 261,554 | 257.4 K to 261.6 K (+1.61 %) |
Aug 17 2017 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Sell | S | 15.00 | 7,000 | 105,000 | 257,409 | 264.4 K to 257.4 K (-2.65 %) |
Aug 17 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Option Exercise | M | 0.00 | 7,697 | 0 | 12,829 | |
Aug 17 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Sell | S | 14.39 | 2,100 | 30,219 | 120,957 | 123.1 K to 121 K (-1.71 %) |
Aug 17 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Sell | S | 14.23 | 2,100 | 29,883 | 123,057 | 125.2 K to 123.1 K (-1.68 %) |
Aug 17 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Buy | M | 0.00 | 7,697 | 0 | 125,157 | 117.5 K to 125.2 K (+6.55 %) |
Aug 17 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Option Exercise | M | 0.00 | 829 | 0 | 1,382 | |
Aug 17 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 14.75 | 7,604 | 112,159 | 355,305 | 362.9 K to 355.3 K (-2.10 %) |
Aug 17 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Buy | M | 0.00 | 829 | 0 | 362,909 | 362.1 K to 362.9 K (+0.23 %) |
Aug 17 2017 | ATRA | Atara Biotherapeut ... | Clark Mitchall G. | EVP & Chief R & QA ... | Option Exercise | M | 0.00 | 7,211 | 0 | 19,231 | |
Aug 17 2017 | ATRA | Atara Biotherapeut ... | Clark Mitchall G. | EVP & Chief R & QA ... | Sell | S | 14.33 | 3,021 | 43,291 | 159,130 | 162.2 K to 159.1 K (-1.86 %) |
Aug 17 2017 | ATRA | Atara Biotherapeut ... | Clark Mitchall G. | EVP & Chief R & QA ... | Buy | M | 0.00 | 7,211 | 0 | 162,151 | 154.9 K to 162.2 K (+4.65 %) |
Aug 17 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Option Exercise | M | 0.00 | 5,908 | 0 | 9,846 | |
Aug 17 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Buy | M | 0.00 | 5,908 | 0 | 737,767 | 731.9 K to 737.8 K (+0.81 %) |
Aug 14 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 14.58 | 2,200 | 32,076 | 446,178 | 448.4 K to 446.2 K (-0.49 %) |
Aug 14 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 14.75 | 2,200 | 32,450 | 448,378 | 450.6 K to 448.4 K (-0.49 %) |
Jul 26 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 16.79 | 200 | 3,358 | 450,578 | 450.8 K to 450.6 K (-0.04 %) |
Jul 26 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 15.97 | 2,500 | 39,925 | 450,778 | 453.3 K to 450.8 K (-0.55 %) |
Jul 26 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 17.32 | 300 | 5,196 | 453,278 | 453.6 K to 453.3 K (-0.07 %) |
Jul 26 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 16.89 | 2,500 | 42,225 | 453,578 | 456.1 K to 453.6 K (-0.55 %) |
Jul 18 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 14.92 | 6,000 | 89,520 | 362,080 | 368.1 K to 362.1 K (-1.63 %) |
Jun 16 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 12.65 | 6,000 | 75,900 | 368,080 | 374.1 K to 368.1 K (-1.60 %) |
Jun 12 2017 | ATRA | Atara Biotherapeut ... | SEIDENBERG BETH C | Director | Option Exercise | A | 13.20 | 21,500 | 283,800 | 21,500 | |
Jun 12 2017 | ATRA | Atara Biotherapeut ... | SEIDENBERG BETH C | Director | Grant | A | 0.00 | 5,000 | 0 | 13,689 | 8.7 K to 13.7 K (+57.54 %) |
Jun 12 2017 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Option Exercise | A | 13.20 | 21,500 | 283,800 | 21,500 | |
Jun 12 2017 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Sell | S | 13.15 | 1,000 | 13,150 | 107,374 | 108.4 K to 107.4 K (-0.92 %) |
Jun 12 2017 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Grant | A | 0.00 | 5,000 | 0 | 108,374 | 103.4 K to 108.4 K (+4.84 %) |
Jun 12 2017 | ATRA | Atara Biotherapeut ... | MARCUS JOEL S | Director | Option Exercise | A | 13.20 | 21,500 | 283,800 | 21,500 | |
Jun 12 2017 | ATRA | Atara Biotherapeut ... | MARCUS JOEL S | Director | Grant | A | 0.00 | 5,000 | 0 | 7,000 | 2 K to 7 K (+250.00 %) |
Jun 12 2017 | ATRA | Atara Biotherapeut ... | HEIDEN WILLIAM K | Director | Option Exercise | A | 13.20 | 21,500 | 283,800 | 21,500 | |
Jun 12 2017 | ATRA | Atara Biotherapeut ... | HEIDEN WILLIAM K | Director | Grant | A | 0.00 | 5,000 | 0 | 7,000 | 2 K to 7 K (+250.00 %) |
Jun 12 2017 | ATRA | Atara Biotherapeut ... | Fust Matthew K | Director | Option Exercise | A | 13.20 | 21,500 | 283,800 | 21,500 | |
Jun 12 2017 | ATRA | Atara Biotherapeut ... | Fust Matthew K | Director | Grant | A | 0.00 | 5,000 | 0 | 27,298 | 22.3 K to 27.3 K (+22.42 %) |
Jun 12 2017 | ATRA | Atara Biotherapeut ... | DOBMEIER ERIC | Director | Option Exercise | A | 13.20 | 21,500 | 283,800 | 21,500 | |
Jun 12 2017 | ATRA | Atara Biotherapeut ... | DOBMEIER ERIC | Director | Grant | A | 0.00 | 5,000 | 0 | 12,500 | 7.5 K to 12.5 K (+66.67 %) |
May 31 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 13.26 | 3,450 | 45,747 | 456,078 | 459.5 K to 456.1 K (-0.75 %) |
May 31 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 13.44 | 3,450 | 46,368 | 459,528 | 463 K to 459.5 K (-0.75 %) |
May 17 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Option Exercise | M | 0.00 | 7,698 | 0 | 20,526 | |
May 17 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Option Exercise | M | 0.00 | 935 | 0 | 0 | |
May 17 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Sell | S | 15.27 | 2,000 | 30,540 | 117,460 | 119.5 K to 117.5 K (-1.67 %) |
May 17 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Sell | S | 14.95 | 2,000 | 29,900 | 119,460 | 121.5 K to 119.5 K (-1.65 %) |
May 17 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Buy | M | 0.00 | 7,698 | 0 | 121,460 | 113.8 K to 121.5 K (+6.77 %) |
May 17 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Buy | M | 0.00 | 935 | 0 | 113,762 | 112.8 K to 113.8 K (+0.83 %) |
May 17 2017 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Option Exercise | M | 0.00 | 817 | 0 | 2,997 | |
May 17 2017 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Option Exercise | M | 0.00 | 1,549 | 0 | 4,645 | |
May 17 2017 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Sell | S | 15.25 | 1,184 | 18,056 | 103,374 | 104.6 K to 103.4 K (-1.13 %) |
May 17 2017 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Buy | M | 0.00 | 817 | 0 | 104,558 | 103.7 K to 104.6 K (+0.79 %) |
May 17 2017 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Buy | M | 0.00 | 1,549 | 0 | 103,741 | 102.2 K to 103.7 K (+1.52 %) |
May 17 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Option Exercise | M | 0.00 | 5,908 | 0 | 15,754 | |
May 17 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Buy | M | 0.00 | 5,908 | 0 | 731,859 | 726 K to 731.9 K (+0.81 %) |
May 17 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Option Exercise | M | 0.00 | 829 | 0 | 2,211 | |
May 17 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 14.99 | 7,604 | 113,984 | 374,080 | 381.7 K to 374.1 K (-1.99 %) |
May 17 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Buy | M | 0.00 | 829 | 0 | 381,684 | 380.9 K to 381.7 K (+0.22 %) |
May 17 2017 | ATRA | Atara Biotherapeut ... | Clark Mitchall G. | EVP & Chief R & QA ... | Option Exercise | M | 0.00 | 7,212 | 0 | 26,442 | |
May 17 2017 | ATRA | Atara Biotherapeut ... | Clark Mitchall G. | EVP & Chief R & QA ... | Sell | S | 15.25 | 3,873 | 59,063 | 153,000 | 156.9 K to 153 K (-2.47 %) |
May 17 2017 | ATRA | Atara Biotherapeut ... | Clark Mitchall G. | EVP & Chief R & QA ... | Buy | M | 0.00 | 7,212 | 0 | 156,873 | 149.7 K to 156.9 K (+4.82 %) |
May 11 2017 | ATRA | Atara Biotherapeut ... | Porter Derrell | SVP, Head of Global ... | Option Exercise | A | 14.30 | 130,000 | 1,859,000 | 130,000 | |
Apr 26 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 17.78 | 3,600 | 64,008 | 467,778 | 471.4 K to 467.8 K (-0.76 %) |
Apr 26 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 17.70 | 1,500 | 26,550 | 471,378 | 472.9 K to 471.4 K (-0.32 %) |
Apr 26 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 17.07 | 2,100 | 35,847 | 472,878 | 475 K to 472.9 K (-0.44 %) |
Apr 19 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 17.28 | 6,000 | 103,680 | 380,855 | 386.9 K to 380.9 K (-1.55 %) |
Apr 12 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 16.99 | 4,200 | 71,358 | 474,978 | 479.2 K to 475 K (-0.88 %) |
Apr 12 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 17.08 | 3,000 | 51,240 | 479,178 | 482.2 K to 479.2 K (-0.62 %) |
Apr 03 2017 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Option Exercise | A | 20.40 | 90,000 | 1,836,000 | 90,000 | |
Apr 03 2017 | ATRA | Atara Biotherapeut ... | Newell Joe | Chief Tech. Operati ... | Grant | A | 0.00 | 7,500 | 0 | 7,500 | 0 to 7.5 K |
Mar 28 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 19.86 | 418 | 8,301 | 482,178 | 482.6 K to 482.2 K (-0.09 %) |
Mar 28 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 18.99 | 3,182 | 60,426 | 482,596 | 485.8 K to 482.6 K (-0.66 %) |
Mar 28 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 20.34 | 12,400 | 252,216 | 485,778 | 498.2 K to 485.8 K (-2.49 %) |
Mar 23 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Sell | S | 21.08 | 6,500 | 137,020 | 112,827 | 119.3 K to 112.8 K (-5.45 %) |
Mar 23 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Sell | S | 20.27 | 7,500 | 152,025 | 119,327 | 126.8 K to 119.3 K (-5.91 %) |
Mar 20 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 20.01 | 17,600 | 352,176 | 498,178 | 515.8 K to 498.2 K (-3.41 %) |
Mar 20 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 18.50 | 2,400 | 44,400 | 515,778 | 518.2 K to 515.8 K (-0.46 %) |
Mar 20 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Sell | S | 18.54 | 10,800 | 200,232 | 518,178 | 529 K to 518.2 K (-2.04 %) |
Mar 17 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 19.60 | 6,000 | 117,600 | 386,855 | 392.9 K to 386.9 K (-1.53 %) |
Mar 13 2017 | ATRA | Atara Biotherapeut ... | Soffer Gad | EVP & Chief Strateg ... | Sell | S | 20.00 | 2,500 | 50,000 | 266,527 | 269 K to 266.5 K (-0.93 %) |
Mar 10 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Sell | S | 20.00 | 24,000 | 480,000 | 126,827 | 150.8 K to 126.8 K (-15.91 %) |
Feb 22 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Sell | S | 15.14 | 9,000 | 136,260 | 150,827 | 159.8 K to 150.8 K (-5.63 %) |
Feb 16 2017 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Option Exercise | M | 0.00 | 817 | 0 | 3,814 | |
Feb 16 2017 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Option Exercise | M | 0.00 | 1,548 | 0 | 6,194 | |
Feb 16 2017 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Sell | S | 16.10 | 1,183 | 19,046 | 102,192 | 103.4 K to 102.2 K (-1.14 %) |
Feb 16 2017 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Buy | M | 0.00 | 817 | 0 | 103,375 | 102.6 K to 103.4 K (+0.80 %) |
Feb 16 2017 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Buy | M | 0.00 | 1,548 | 0 | 102,558 | 101 K to 102.6 K (+1.53 %) |
Feb 16 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Option Exercise | M | 0.00 | 7,697 | 0 | 28,224 | |
Feb 16 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Option Exercise | M | 0.00 | 2,804 | 0 | 935 | |
Feb 16 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Buy | M | 0.00 | 7,697 | 0 | 159,827 | 152.1 K to 159.8 K (+5.06 %) |
Feb 16 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Buy | M | 0.00 | 2,804 | 0 | 152,130 | 149.3 K to 152.1 K (+1.88 %) |
Feb 16 2017 | ATRA | Atara Biotherapeut ... | Fust Matthew K | Director | Option Exercise | M | 0.00 | 1,603 | 0 | 6,944 |